ArticleHealth science reports2026
Prevalence and Risk Factors for Diabetic Peripheral Neuropathy Among Malagasy Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Diabetic peripheral neuropathy (DPN) is the most prevalent complication of diabetes, leading to functional impairment and a decline in patients' quality of life. The objectives of the present study were to determine the prevalence and risk factors for DPN in Malagasy patients with type 2 diabetes (T2DM). Methods: A cross-sectional study was conducted in the Internal Medicine and Cardiovascular Diseases Departments of the Soavinandriana hospital center over a 3-year period. The diagnosis of NPD was made in the presence of a DN4 questionnaire score ≥ 4, impaired sensitivity to a 10 g monofilament and reduced or absent ankle reflexes. Results: Among the 289 T2DM, the prevalence of DPN was 28.7%. After multivariate analysis, risk factors for DPN were age ≥ 60 years (OR 2.21 (1.19-4.08)), dyslipidemia (OR 3.38 (1.52-7.52)), microalbuminuria (OR 6.55 (3.69-11. 6)), diabetes duration ≥ 10 years (OR 2.92 (1.54-5.53)), glycated hemoglobin ≥ 7% (OR 2.43 (1.08-5.49)), nephropathy (OR 12.8 (6.71-24.3)) and retinopathy (OR 2.32 (1.25-4.31)). Conclusion: DPN was a prevalent comorbidity among Malagasy patients with T2DM. The risk factors were consistent with those documented in the literature. The primary strategy for preventing DPN is the effective management of diabetes and modifiable risk factors.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.